SRZN: DUET study launches this year to test dual VEGF/Wnt therapy in DME, targeting clinical differentiation
The DUET clinical study will launch later this year, evaluating a dual VEGF/Wnt molecule in DME with Vabysmo as comparator, focusing on safety, durability, and unique reperfusion endpoints. Strong preclinical data, robust IP, and upcoming milestones—including IND clearance and new financing—positio…